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Berries are traditionally an important part of the daily diet in many Nordic countries. 
In addition of being healthy in general, berries have a long history in folk medicine. 
Bilberry, for example, has been used as a medicinal herb for treatment of diarrhea, 
and cranberry for urinary infections. Many positive health effects of berries are 
believed to be associated to phenolic compounds, which berries are rich in. Phenolic 
compounds are reported to have a variety of beneficial biological properties. They are 
potent antioxidants, and exhibit various other physiological activities including anti-
inflammatory, antimicrobial, antiallergic, anticarcinogenic and antihypertensive 
activities in in vitro assays or in cell or animal models. However, there is very little 
scientific or clinical data available of their efficiency in maintaining health and 
preventing diseases.  Best-defined clinical evidence is most propably associated to 
cranberry and its preventive effects against urinary tract infections. 
 
Antimicrobial activity of the berry compounds has attracted interest, because recent 
studies suggest that they may affect the behaviour of human pathogenic bacteria. 
Pathogenic bacteria or toxins produced by bacteria often enter human body via food or 
drink causing symptoms or illness. Salmonella enterica sv. Typhimurium, as an 
example, have caused foodborne and waterborne outbreaks of GI tract infections in 
human, and Staphylococcus aureus is a causative agent of food poisoning by 
producing toxin in food, followed by toxic symptoms in human. It has been suggested 
that the profile of phytochemicals that are present in natural sources, such as berries, 
confer a broad spectrum of antimicrobial capacity and potentially limit the 
development of antimicrobial resistance because of their possible differences in modes 
of action. Several mechanisms of action in the growth inhibition of bacteria are 
involved, such as destabilization of cytoplasmic membrane, permeabilization of plasma 
membrane, inhibition of extracellular microbial enzymes, direct actions on microbial 
metabolism and deprivation of the substrates required for microbial growth. 
Antimicrobial activity of berries may also be related to antiadherence of bacteria to 
epithelial cells, which is a prerequisite for colonization and infection of many 
11pathogens. The antiadherence properties have so far been reported to cranberry 
phenolics.  
 
Berries, especially their antimicrobial properties, have been intensively studied at VTT 
over the past ten years in several research projects. In these in vitro studies phenolic 
berry extracts of common Nordic berries selectively inhibited the growth of harmful 
bacteria and human intestinal pathogens, without affecting the growth of beneficial 
lactic acid bacteria. Salmonella and Staphylococcus strains were the most sensitive 
bacteria, and cloudberry and raspberry the most efficient berries. Campylobacter 
jejuni and Candida albicans were inhibited only with phenolic extracts of cloudberry, 
raspberry, and strawberry, which all were rich in ellagitannins. As a consequence of 
antimicrobial activity, diet rich in berries may affect on composition of intestinal 
microbiota. So far no in vivo data is available of the effects of berry phenolics on 
human gastrointestinal microbiota.  
 
In on-going BERRYDRUG project at VTT, phenolic compounds present in berries are 
studied for utilization in functional foods and in drug development.  Selected berry 
extracts are screened in vitro especially against human pathogens causing 
gastrointestinal and urinary tract  infections.  An important aspect in the present study 
is a human clinical study carried out with volunteers who have consumed a berry rich 
diet over a certain period of time. The analyses of this trial, which  focuses on 
intestinal microbiota and subsequent microbial conversions, are going on. This reseach 
project BERRYDRUG (2005-2008, financially supported by Tekes) is coordinated by 
VTT, and performed in collaboration with University of Helsinki, University of Tampere 
and University of Kuopio.  
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